Sarkar S Neil, Tracy Derek K, Fernandez Maria-Jesus Mateos, Nalesnik Natasza, Dhillon Gurbinder, Onwumere Juliana, Prins Anne-Marye, Schepman Karen, Collier Tracy, White Thomas P, Patel Anita, Gaughran Fiona, Shergill Sukhwinder S
Central and North West London NHS Foundation Trust ; Cognition, Schizophrenia and Imaging Laboratory, Department of Psychosis Studies, Institute of Psychiatry, King's College London.
Cognition, Schizophrenia and Imaging Laboratory, Department of Psychosis Studies, Institute of Psychiatry, King's College London ; Oxleas NHS Foundation Trust, London.
Psychiatr Bull (2014). 2014 Apr;38(2):71-4. doi: 10.1192/pb.bp.112.042598.
Aims and method In up to a quarter of patients, schizophrenia is resistant to standard treatments. We undertook a naturalistic study of 153 patients treated in the tertiary referral in-patient unit of the National Psychosis Service based at the Maudsley Hospital in London. A retrospective analysis of symptoms on admission and discharge was undertaken using the OPCRIT tool, along with preliminary economic modelling of potential costs related to changes in accommodation. Results In-patient treatment demonstrated statistically significant improvements in all symptom categories in patients already identified as having schizophrenia refractory to standard secondary care. The preliminary cost analysis showed net savings to referring authorities due to changes from pre- to post-discharge accommodation. Clinical implications Despite the enormous clinical, personal and societal burden of refractory psychotic illnesses, there is insufficient information on the outcomes of specialised tertiary-level care. Our pilot data support its utility in all domains measured.